BeStock  

Haemonetics HAE

US equityMarket cap rank #1950Medical Devices
$120.16 −$0.21 (-0.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $120.16 0.00%
Open$120.37
Prev close$120.37
Day range$119.68 – $122.34
Volume383.0K
Market cap$5.47B
P/E (TTM)53.2
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Sep 2026

Revenue$357.76M+9.3% YoY
Operating profit$75.12M+12.0% YoY
Net profit$46.31M+19.7% YoY
Diluted EPS$1.00+23.5% YoY
Free cash flow$113.33M+6.6% YoY
Operating cash flow$128.10M

Revenue, last 8 quarters

$348.5MDec '24$330.6MMar '25$321.4MJun '25$327.3MSep '25$339.0MDec '25$346.4MMar '26$339.4MJun '26$357.8MSep '26

Net profit, last 8 quarters

$37.5MDec '24$58.0MMar '25$34.0MJun '25$38.7MSep '25$44.7MDec '25$-20.1MMar '26$33.0MJun '26$46.3MSep '26

Diluted EPS by quarter

0.74Dec '241.17Mar '250.70Jun '250.81Sep '250.95Dec '25-0.44Mar '260.72Jun '261.00Sep '26

Free cash flow by quarter

$35.2MDec '24$100.9MMar '25$13.6MJun '25$106.3MSep '25$87.2MDec '25$53.3MMar '26$44.4MJun '26$113.3MSep '26

Annual revenue

$870.5MFY21$993.2MFY22$1.2BFY23$1.3BFY24$1.4BFY25$1.3BFY26

Profitability & balance sheet

Gross margin59.6%
Operating margin18.3%
Net margin7.5%
Return on equity11.9%
Return on assets4.3%
Return on invested capital6.3%
Current ratio2.84
Liabilities / assets62.7%
Cash & investments$260.71M
Total debt$1.12B
Net cash (debt)-$863.05M
Free cash flow / sales21.6%

Where the revenue comes from

Quarter 2027/Q2

By business line

  • Apheresis$204.81M 57.2%
  • MedSurg$152.95M 42.8%

Income statement

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Revenue as Reported $357.76M $339.38M $1.33B $346.35M $338.97M
Total Operating Revenue $357.76M $339.38M $1.33B $346.35M $338.97M
Cost of Revenue $136.85M $136.58M $546.44M $148.14M $136.58M
Gross Profit $220.91M $202.80M $787.59M $198.21M $202.39M
Operating Expense $145.79M $145.35M $546.19M $145.87M $134.27M
Selling and Admin Expenses $118.36M $118.94M $442.42M $120.93M $109.15M
Research & Development $17.03M $16.20M $59.77M $14.45M $14.19M
Depreciation & Amortization & Depletion $10.40M $10.20M $44.00M $10.49M $10.93M
-Depreciation & Amortization $10.40M $10.20M $44.00M $10.49M $10.93M
Operating Profit $75.12M $57.46M $241.40M $52.34M $68.11M
Net Non-Operating Interest Income (Expense) -$12.26M -$9.88M -$28.70M -$5.37M -$7.42M
Non-Operating Interest Expense $12.26M $9.88M $28.70M $5.37M $7.42M
Special Income (Charges) $0.00 – -$84.67M -$75.37M -$716,000.00
-Less:Impairment of Capital Assets $0.00 – $86.55M $77.25M $716,000.00
Pretax Profit $62.86M $47.57M $128.03M -$28.40M $59.98M
Tax $16.55M $14.56M $30.72M -$8.25M $15.24M
Net Profit $46.31M $33.01M $97.31M -$20.15M $44.74M
Profit from Continuing Operations $46.31M $33.01M $97.31M -$20.15M $44.74M
Net Income to Parent Company $46.31M $33.01M $97.31M -$20.15M $44.74M
Net Income to Common Stockholders $46.31M $33.01M $97.31M -$20.15M $44.74M
Basic EPS $1.02 $0.73 $2.06 -$0.44 $0.96
Diluted EPS $1.00 $0.72 $2.05 -$0.44 $0.95
Other Income (Expense) – – -$84.67M -$75.37M -$716,000.00
-Less:Restructuring and Mergern & Acquisition – – -$1.88M – –

Balance sheet

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Total Assets $2.41B $2.37B $2.40B $2.40B $2.49B
Total Current Assets $855.53M $810.83M $834.88M $834.88M $943.67M
Cash and Cash Equivalents & Short-Term Investments $260.71M $223.38M $245.44M $245.44M $363.37M
-Cash and Cash Equivalents $260.71M $223.38M $245.44M $245.44M $363.37M
Receivables $224.95M $216.07M $216.86M $216.86M $195.71M
-Accounts Receivable $224.95M $216.07M $216.86M $216.86M $195.71M
Inventory $305.01M $306.74M $306.37M $306.37M $321.19M
Other Current Assets $64.86M $64.64M $66.21M $66.21M $63.42M
Total Non-Current Assets $1.56B $1.55B $1.56B $1.56B $1.55B
Net PPE $307.92M $303.78M $305.76M $305.76M $297.23M
-Gross PPE $873.32M $854.27M $841.83M $841.83M $836.81M
-Accumulated Depreciation -$565.40M -$550.49M -$536.07M -$536.07M -$539.58M
Goodwill and Other Intangible Assets $1.08B $1.09B $1.10B $1.10B $1.03B
-Goodwill $657.10M $656.88M $656.37M $656.37M $606.83M
-Other Intangible Assets $426.36M $434.51M $447.66M $447.66M $419.73M
Non-Current Deferred Assets $9.35M $9.43M $9.52M $9.52M $7.33M
Other Non-Current Assets $154.34M $149.96M $141.74M $141.74M $216.09M
Total Liabilities $1.51B $1.53B $1.60B $1.60B $1.58B
Total Current Liabilities $300.84M $263.24M $282.60M $282.60M $539.87M
Payables $71.64M $56.34M $51.06M $51.06M $48.69M
-Accounts Payable $71.64M $56.34M $51.06M $51.06M $48.69M
Current Accrued Expenses $54.42M $38.15M $68.19M $68.19M $52.10M
Short-Term Debt and Capital Lease Obligation $9.64M $4.96M $5.02M $5.02M $304.75M
-Current Debt $9.64M $4.96M $5.02M $5.02M $304.75M
Other Current Liabilities $165.13M $163.80M $116.03M $116.03M $134.33M
Total Non-Current Liabilities $1.21B $1.27B $1.32B $1.32B $1.04B
Long Term Debt and Capital Lease Obligation $1.11B $1.17B $1.22B $1.22B $919.99M
-Long Term Debt $1.11B $1.17B $1.22B $1.22B $919.99M
Non-Current Deferred Liabilities $41.82M $38.69M $38.05M $38.05M $55.98M
Other Non-Current Liabilities $55.33M $57.17M $59.39M $59.39M $63.61M
Total Equity $898.50M $837.10M $796.32M $796.32M $911.45M
Stockholders' Equity $898.50M $837.10M $796.32M $796.32M $911.45M
Capital Stock $455,000.00 $455,000.00 $453,000.00 $453,000.00 $468,000.00
-Common Stock $455,000.00 $455,000.00 $453,000.00 $453,000.00 $468,000.00
Additional Paid-In Capital $579.80M $566.76M $554.14M $554.14M $564.50M
Retained Earnings $356.96M $311.52M $279.34M $279.34M $381.09M
Gains/Losses Not Affecting Retained Earnings -$38.72M -$41.63M -$37.61M -$37.61M -$34.61M
Current Deferred Liabilities – – $42.31M $42.31M –

Cash flow

Line item 2027 Q2 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3
Operating Cash Flow $128.10M $52.32M $293.22M $70.94M $93.56M
Net cash flow from continuing operations $128.10M $52.32M $293.22M $70.94M $93.56M
Net Income from Continuing Operations $46.31M $33.01M $97.31M -$20.15M $44.74M
Depreciation & Depletion & Amortization $27.76M $27.11M $111.72M $27.32M $27.39M
Deferred Tax $2.57M $668,000.00 -$714,000.00 $5.30M -$2.06M
Other Non-Cash Items $3.16M $2.23M $3.94M -$6.63M $3.71M
Change in Working Capital $38.08M -$20.00M -$12.93M $4.66M $11.81M
-Change in Receivables -$8.36M $297,000.00 -$14.88M -$22.24M $11.06M
-Change in Inventory $1.98M -$1.00M $47.36M $8.46M $13.84M
-Change in Prepaid Assets -$3.67M $6.10M -$4.53M -$5.89M -$1.78M
-Change in Payables and Accrued Expense $53.63M -$12.62M -$16.57M $20.32M -$6.70M
-Change In Other Working Capital -$5.49M -$12.78M -$24.30M $4.00M -$4.61M
Net cash flow from investing -$24.29M -$22.23M -$179.55M -$86.61M -$29.47M
Net Cash Flow from Continuing Investing Activities -$24.29M -$22.23M -$179.55M -$86.61M -$29.47M
Capital Expenditure -$14.77M -$7.91M -$32.78M -$17.66M -$6.35M
Net PPE Purchase and Sale $576,000.00 $237,000.00 $1.38M $526,000.00 $432,000.00
Net Other Investing Changes -$19.09M -$5.57M -$51.89M $26.77M -$23.55M
Financing Cash Flow -$67.61M -$51.53M -$178.46M -$101.50M $2.03M
Net Cash Flow from Continuing Financing Activities -$67.61M -$51.53M -$178.46M -$101.50M $2.03M
Net Issuance Payments Of Debt -$51.56M -$51.56M -$6.25M -$1.56M -$1.56M
Proceeds from Stock Option Exercised $1.56M $49,000.00 $2.89M $76,000.00 $3.61M
Net Other Financing Charges -$17.61M -$14,000.00 -$102,000.00 -$13,000.00 -$14,000.00
Ending Cash Balance $260.71M $223.38M $245.44M $245.44M $363.37M
Net Change in Cash $36.20M -$21.44M -$64.79M -$117.17M $66.13M
Beginning Cash Balance $223.38M $245.44M $306.76M $363.37M $296.43M
Effect of Exchange Rate Changes $1.13M -$617,000.00 $3.46M -$756,000.00 $810,000.00
Free Cash Flow $113.33M $44.42M $260.44M $53.28M $87.22M
Net Investment Purchase and Sale – -$9.00M -$36.07M – –
Gain/Loss from Continuing Operations – – -$26.47M -$25.94M -$218,000.00
Net Business Purchase and Sale – – -$60.18M -$60.18M $0.00
Net Common Stock Issuance – – -$175.00M -$100.00M $0.00

Discussion

No comments yet — be the first to weigh in on HAE.

Sign in to join the discussion.

Scroll to Top